Errata: Vol. 62, No. RR-03

	MMWR Weekly Volume 62, No. 35 September 6, 2013

Errata: Vol. 62, No. RR-03

Weekly

September 6, 2013 / 62(35);730

In the Recommendations and Reports, "Diagnosis and Management of Q Fever — United States, 2013: Recommendations from CDC and the Q Fever Working Group" on page 6, in Table 2, the following errors occurred.
In the third column, "Children," the recommended treatment of acute Q fever for children aged < 8 years with mild or uncomplicated illness, should read as follows: "Doxycycline 2.2 mg/kg per dose twice a day for 5 days (maximum 100 mg per dose). If patient remains febrile past 5 days of treatment: trimethoprim/sulfamethoxazole 4–20 mg/kg/24 hours (dose based on trimethoprim component) in equally divided doses every 12 hours (maximum: 320 mg trimethoprim per 24 hours)"
In the fourth column, "Pregnant women," the recommended treatment of acute Q fever for pregnant women should read as follows: "Trimethoprim/sulfamethoxazole: 160 mg/800 mg twice a day throughout pregnancy but not beyond 32 weeks' gestation††
In the ¶ footnote, the following sentence should be added at the end: "Trimethoprim/sulfamethoxazole is contraindicated in children aged < 2 months."
In the †† footnote, the following sentence should be added at the end: "Trimethoprim/sulfamethoxazole should be discontinued for the final 8 weeks of pregnancy because of the risk for hyperbilirubinemia."